About Careers MedBlog Contact us
Medindia LOGIN REGISTER
Advertisement

Herbicide Glyphosate Does Not Pose Risk of Cancer: WHO

by Reshma Anand on May 17, 2016 at 2:21 PM
Font : A-A+

Herbicide Glyphosate Does Not Pose Risk of Cancer: WHO

United Nations finds that the controversial weed killer glyphosate, which is used by Monsanto in its herbicide Roundup, is "unlikely" to cause cancer.

Last month, the European parliament urged the EU to only approve glyphosate's use for seven years instead of 15 as requested by the bloc's top regulator amid fears that the product could be carcinogenic.

Advertisement


A review carried out by pesticide experts from the World Health Organization and the Food and Agriculture Organization said "glyphosate is unlikely to pose a carcinogenic risk to humans from exposure through the diet."

That appeared to contradict a March 2015 finding from the WHO's International Agency for Research on Cancer (IARC) which said glyphosate "probably" caused cancer.
Advertisement

WHO said the two findings were not contradictory.

It said the IARC finding was based on whether glyphosate could potentially pose any "hazard" to human health, including in extremely high levels of exposure.

The joint WHO/FAO panel reviewed all available evidence to assess specific risk to people consuming limited quantities of the chemical through food.

The earlier WHO finding was cited by activists led by Greenpeace who called for the ingredient's outright ban.

In March, regulators from the 28 EU members states, in addition to the European Commission, delayed their decision on rolling over the approval for glyphosate amid fierce lobbying from both sides of the issue.

The EU pesticides committee is set to meet to decide on whether to extend glyphosate's license.

The latest UN findings could tip the decision in favor of agriculture giant Monsanto, which has fought hard to secure market approval for its key product.

Among major EU member states, France and Austria have expressed opposition to glyphosate, while Britain and Germany are said to support its use generally.

Source: AFP
Advertisement

Advertisement
Advertisement

Latest Cancer News

Why Is Time of Day Important in Cancer Diagnosis and Treatment?
Chronotherapy (the sleep-wake cycle) is observed as a valuable alternative treatment in cancer diagnosis and treatment.
How Do Neutrophils Impact Pancreatic Cancer Treatment Resistance?
A nanoengineering platform targets neutrophils, the white blood cells without killing pancreatic cancer cells paving the way for effective treatments.
Lung Cancer: The Survival Advantage of Lobectomy Over Wedge Resection
The survival rates between lobectomy and wedge resection surgical procedures were found to be the same among lung cancer patients.
Could TKI Cancer Drugs Lead to Inflammatory Side Effects?
The mechanism by which the kinases cause inflammation has been discovered by scientists.
Are Biomarkers the Key to Identifying Early Pancreatic Risk?
Pancreatic cancer cases are on the rise. The biomarker approach could reduce the chance of developing pancreatic cancer.
View All
This site uses cookies to deliver our services.By using our site, you acknowledge that you have read and understand our Cookie Policy, Privacy Policy, and our Terms of Use  Ok, Got it. Close
×

Herbicide Glyphosate Does Not Pose Risk of Cancer: WHO Personalised Printable Document (PDF)

Please complete this form and we'll send you a personalised information that is requested

You may use this for your own reference or forward it to your friends.

Please use the information prudently. If you are not a medical doctor please remember to consult your healthcare provider as this information is not a substitute for professional advice.

Name *

Email Address *

Country *

Areas of Interests